Blossomhill Therapeutics
Clinical trials sponsored by Blossomhill Therapeutics, explained in plain language.
-
New hope for lung cancer: targeted pill takes on tough mutations
Disease control Recruiting nowThis study tests an experimental drug, BH-30643, in people with advanced non-small cell lung cancer that has certain changes in the EGFR or HER2 genes. The goal is to find a safe dose and see if the drug can shrink tumors. About 266 adults who have already tried standard treatmen…
Phase: PHASE1, PHASE2 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New pill shows promise for Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial tests a new daily pill, BH-30236, for adults with acute myeloid leukemia (AML) or a high-risk pre-leukemia condition (MDS) that has returned or not responded to prior treatments. The study will first find the safest dose, then test it alone or with another …
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:39 UTC